Clinical Trials

Phase 1 / 2 trial of Idasanutlin in combination with Ixazomib and dexamethasone in patients with 17p deleted, relapsed multiple myeloma


Study ID
MMRC-Mayo Clinic MC1582 MMRC-061

NCT Number
NCT02633059 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0634

Principle Investigator
Dr. David Vesole

Phase
I/II

Sponsor
Mayo Clinic


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now